Evaluate Protective Efficacy of Diff Strengths of Human Rotavirus Vaccine After Admn of 2 Doses to Infants Aged 2 Months

Clinical trial NCT00385320 · COMPLETED

Trial details

NCT number: NCT00385320
Sponsor: GlaxoSmithKline
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Infections, Rotavirus

Start date: 2001-05-31
Primary completion: 2003-04-30
Enrollment: 2640

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.